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Abstract
Background: Trypanosoma cruzi is a protozoan pathogen of major medical importance in Latin
America. It is also an early diverging eukaryote that displays many unusual biochemical features. The
completion of the T. cruzi genome project has highlighted the need to extend the range of
techniques available to study gene function. To this end we report the development of a stable
tetracycline-dependent expression vector applicable to this parasite and describe in detail the
parameters of the system.
Results: We first produced T. cruzi cell lines that constitutively expressed bacteriophage T7 RNA
polymerase and the tetracycline repressor protein from a multicopy episome. An integrative vector
with an inducible expression site under the control of a tetracycline-regulatable T7 promoter
(pTcINDEX) was targeted to the transcriptionally silent ribosomal RNA spacer region of these
parasites and transformants selected using a T7 RNA polymerase-dependent hygromycin
resistance gene. To test the system we used two marker proteins, luciferase and red fluorescent
protein (RFP), and an endogenous parasite protein (a mitochondrial superoxide dismutase). In each
case we found that induction was both time and dose-dependent. Luciferase mRNA could be
induced by at least 100-fold, and luciferase activity up to 60-fold, within 24 hours of the addition of
tetracycline. When we examined RFP induction by confocal microscopy and fluorescence activated
cell sorter, we observed very high levels of expression (>1000-fold increase in fluorescence
intensity), although this was not synchronous throughout clonal populations. Induction of
superoxide dismutase resulted in an 18-fold increase in cellular activity. The observation that a
tagged version of the enzyme was correctly targeted to the mitochondrion demonstrates that our
expression system may also provide a high-throughput strategy for subcellular localisation.
Conclusion: Our results show that pTcINDEX represents a valuable addition to the genetic tools
available for T. cruzi. The vector system is sufficiently flexible that it should have widespread uses
including inducible expression of tagged proteins, generation of conditional knockout cell lines and
the application of dominant-negative approaches.
Background
Trypanosoma cruzi, the agent of Chagas disease, is a mem-
ber of the Kinetoplastidae, an early-diverging group of
protozoa. This organism is the most important parasite in
Latin America, while its close relatives Trypanosoma brucei
and Leishmania cause African sleeping sickness and the
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leishmaniases respectively. In addition to their medical
and veterinary significance, trypanosomes have been
studied as examples of primitive eukaryotes. They show
several biological peculiarities which have made them
subjects of great interest. These include polycistronic tran-
scription, trans-splicing of mRNA, mitochondrial RNA
editing, compartmentalisation of glycolysis and the utili-
sation of a unique thiol, trypanothione, in place of glu-
tathione. Genome sequencing projects have recently been
completed for each of the human pathogenic trypano-
somatids, T. cruzi, T. brucei and Leishmania [1-3]. To fully
exploit this vast amount of information it is essential that
efforts are made to improve and extend the range of tools
available for analysing the function of genes in vivo. This
is particularly the case with T. cruzi, where technical limi-
tations currently restrict analysis of biological function.
The last few years have seen an explosion of new data on
gene function in T. brucei, largely due to the development
of regulated systems that allow inducible expression of
both protein and double-stranded RNA [4-9]. These sys-
tems can facilitate the study of gene function by over-
expression [10], conditional knockout [11], or by RNA
interference (RNAi)-mediated down-regulation of gene
expression [8,9,11,12]. RNAi is currently the method of
choice for the analysis of gene function in T. brucei and
can be used to inform studies on T. cruzi and Leishmania
genes which have orthologues in T. brucei. However many
trypanosomatid genes are species-specific [13]. Since T.
cruzi lacks the machinery for RNAi, specifically the AGO1
gene [14,15], our unpublished observations), approaches
such as gene deletion or expression of dominant-negative
mutant proteins are of critical importance for studying
function. However, both gene knockout and expression of
mutant proteins can produce a lethal or deleterious phe-
notype. It would therefore be advantageous to have a sys-
tem that allows expression of transgenes in a controlled
and repressible manner.
In general, trypanosomes do not appear to control expres-
sion of protein coding genes at the level of transcription
initiation. The exceptions to this are the major surface
glycoprotein genes of procyclic, metacyclic and blood-
stream forms of T. brucei [16,17], where RNA polymerase
I (pol I)-dependent promoters can drive expression in a
developmental and locus specific manner. RNA polymer-
ase II (pol II)-dependent promoters for protein coding
genes have not been unequivocally identified in trypano-
somatids and there are no known examples of inducible
transcription units. Consequently, it has been necessary to
import regulatable genetic machinery from other organ-
isms to create artificial inducible expression systems. Such
a system for T. brucei was first developed by Wirtz and
Clayton [4]. This relies on the bacterial tetracycline repres-
sor protein (tetR) to block transcription from an engi-
neered promoter in the absence of tetracycline. On
addition of tetracycline, the repressor is released from the
DNA and transcription is allowed to proceed. Initially, use
was made of the T. brucei procyclin promoter [4]. How-
ever, the system was found to be tightly regulated to a sim-
ilar degree when a bacteriophage T7 promoter was utilised
[7]. This necessitated the integration of a T7 RNA
polymerase gene into a transcriptionally active region of
the trypanosome genome prior to insertion of the con-
struct containing the inducible gene. A similar regulatable
expression system has now also been described for Leish-
mania based on an inducible copy of the endogenous
ribosomal RNA (rRNA) promoter [18].
In T. cruzi, inducible expression following transient trans-
fection with a plasmid has been reported [19]. More
recently a stable system has been reported by DaRocha et
al. [15], in which the T7 polymerase and tetR genes were
inserted into the tubulin gene array together with the
strong rRNA promoter. The effects, if any, of this promoter
on expression of endogenous genes flanking the insertion
were not described, although a similar vector used in T.
brucei caused upregulation of genes downstream of the
integration site [20]. Detailed characterisation of this
inducible cell line was not undertaken to assess the
parameters of regulated expression. There have been no
further reports on its use or applications.
Here we describe a stable tetracycline-inducible expres-
sion vector for T. cruzi that circumvents some of the
potential problems associated with integration into an
endogenously transcribed locus. The system is based on
an integrative vector that facilitates inducible expression
of specific genes in a transcriptionally quiescent locus and
engineered cell lines that constitutively express the T7
RNA polymerase and tetR genes from an episomal back-
ground. These experiments now provide a framework for
using stable inducible expression as a tool for studying
gene function in T. cruzi.
Results
Production of cell lines stably expressing tetR and T7 RNA 
polymerase
Plasmid pLEW13, a construct designed to target the T. bru-
cei β-tubulin locus, contains both T7 RNA polymerase and
tetR genes with neo as a selectable marker [7] (Fig. 1A). We
electroporated T. cruzi CL-Brener epimastigotes with cir-
cular pLEW13 DNA (a gift from George Cross) and
selected recombinant parasites on 200 µg ml-1 G418. Sta-
bly transformed parasites were obtained after six weeks,
even though this vector contains no T. cruzi-derived
sequences. Southern analysis showed that the transform-
ants contained multiple copies of the input construct
organised in a tandem array (data not shown). Circular
DNA in transformed T. cruzi usually replicates as an epi-
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Production of cell lines stably expressing tetR and T7 RNA polymeraseFigure 1
Production of cell lines stably expressing tetR and T7 RNA polymerase. (A) Simplified map of pLEW13 indicating the 
relative locations of the three transgenes [7]. (B) CHEFE analysis of chromosomal DNA isolated from CL-Brener [pLEW13] 
epimastigotes showing aberrant migration of the pLEW13 DNA. Lanes 1–3, a 0.8% PFC agarose CHEFE gel (auto-algorithm set 
for 300 kb-3 Mb separation). Lanes 1 (Saccharomyces cerevisiae size standards (Bio-Rad)) and 2 (CL-Brener [pLEW13]), the 
ethidium bromide stained gel. Lane 3, an autoradiograph obtained with the T7 RNA polymerase probe. Lanes 4–6, a 1.0% PFC 
agarose CHEFE gel (auto-algorithm set for 300 kb-1 Mb). Lanes 4 (S. cerevisiae size standards) and 5 (CL-Brener [pLEW13]), 
the ethidium bromide stained gel. Lane 6 is an autoradiograph obtained with the T7 RNA polymerase probe. Molecular sizes 
are given in kb. (C) Expression of the transgenes for T7 RNA polymerase and tetR in pLEW13 transformed epimastigotes. 10 
µg total RNA was blotted and hybridised with either the T7 RNA polymerase (T7 POL) or tetR probes. (D) Splice acceptor 
sites used by T. cruzi to process the transcripts as mapped by RT-PCR. The AG dinucleotide sites of spliced leader addition 
identified following sequencing of the RT-PCR products are red and underlined. The numbers adjacent to the boxes indicate 
the distance in nucleotides between the sequence shown and the start codon of each gene. The T7 RNA polymerase is flanked 
by the T. brucei procyclin spliced leader acceptor site, whereas both neo and tetR are flanked by T. brucei actin spliced leader 
acceptor sites. In the case of the T7 RNA polymerase and tetR transcripts, only one addition site was identified; in the case of 
the neo transcript, three were found.
T7 Pol neo tetR
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B) 1        2                 3                         4        5 6
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some of head-to-tail repeats of the input construct [21].
However, since the vector contained T. brucei β-tubulin
coding sequences, which are very similar to the corre-
sponding T. cruzi gene (88% overall nucleotide identity,
up to 96% in some regions), it was important to establish
whether the pLEW13 tandem array was a circular episome
or had resulted from multiple integrations into the tubu-
lin locus.
Circular molecules show aberrant migration on pulsed
field gels as their movement is independent of their
molecular mass, in contrast to linear chromosomes. DNA
from CL-Brener epimastigotes transformed with pLEW13
(CL-Brener [pLEW13]) was therefore subjected to con-
tour-clamped homogenous electric field gel electrophore-
sis analysis (CHEFE) under differing separation
conditions (Fig. 1B). Using parameters designed to sepa-
rate the larger molecules (up to 3 Mb), the T7 RNA
polymerase probe hybridised to a band of approximately
2 Mb and to a smear of higher molecular weight material
(Fig. 1B lane 3). When the DNA was fractionated under
conditions optimal for separation of molecules of
between 300 kb and 1 Mb, the hybridising band ran at
680 kb, again accompanied by a smear of apparently
higher molecular weight material (Fig. 1B lane 6). The
migration of the pLEW13 construct is therefore independ-
ent of its molecular weight indicative of a circular episome
containing multiple copies of the T7 RNA polymerase and
tetR genes. Southern analysis of genomic DNA also indi-
cated no linkage between the T. cruzi α-tubulin genes and
the T7 RNA polymerase (data not shown).
To check expression of the transfected genes, RNA was
prepared and analysed by northern blotting. This showed
that both T7 RNA polymerase and the tetR gene were
expressed at high levels (Fig. 1C). In trypanosomes each
mRNA is processed by trans-splicing which results in the
addition of a 5' spliced leader sequence of 39 nucleotides
[22]. Since the RNA processing signals in pLEW13 were
derived from T. brucei it was necessary to establish that the
transgenic mRNAs were correctly spliced. For each gene,
primers were designed to sequences approximately 150–
250 bp into the ORF and used in conjunction with a
primer to the T. cruzi spliced leader in an RT-PCR reaction
(Methods). The resulting products were cloned and
sequenced. Each splice addition site could be mapped to
an AG dinucleotide located downstream of a polypyrimi-
dine tract (Fig. 1D). In the case of the T. brucei actin inter-
genic sequence upstream of neo, three separate splice sites
were identified, all of which were upstream of the start
codon. Only one of these was identified in the tetR mRNA
which has the same flanking sequence. In the case of the
procyclin splice acceptor site upstream of the T7 RNA
polymerase, only the site previously mapped in T. brucei
was utilised [23]. This analysis indicated that the T. brucei
RNA processing signals were being correctly utilised by T.
cruzi and that the T7 RNA polymerase and tetR mRNAs
were therefore likely to be functional.
Features of the tetracycline inducible expression vector
The inducible expression vector pTcINDEX (Fig. 2A) was
designed to integrate into the non-transcribed ribosomal
RNA spacer region upstream of the pol I-mediated tran-
scription start site [24] (Methods). We targeted this region
because, to our knowledge, it is the only section of the T.
cruzi genome so far identified as being transcriptionally
silent. In addition, the level of sequence conservation at
this locus suggested that the construct could be targeted to
the corresponding region in multiple parasite strains. The
targeting fragment is cloned as a Sac I cassette which can
be readily replaced to allow integration elsewhere in the
genome.
As a drug selectable marker we used the hygromycin B
phosphotransferase (hyg) gene under the control of a non-
repressible T7 promoter, thus converting antibiotic resist-
ance into a digenic trait. In pLEW13 transformed cells that
constitutively express the T7 RNA polymerase, this
arrangement serves a second function. In the presence of
hygromycin, the requirement for T7 RNA polymerase to
drive expression of hyg removes the necessity for the con-
tinued use of G418 to maintain the pLEW13 construct
and selects for trypanosomes with active T7 RNA polymer-
ase. The inducible expression cassette in the pTcINDEX
vector contains a tetracycline-dependent T7 promoter,
with the tet operator sequence (tetO, cCTATCAgTGAT-
AGa, where upper case indicates bases important in tetR
binding) placed immediately downstream. The multiple
cloning site is flanked at its 3'-end by the intergenic
sequence from the T. cruzi actin locus to provide a polya-
denylation signal, and at the 5'-end by the splice acceptor
site from the ribosomal protein P2β locus. Sequences
from this region have been shown to enhance the expres-
sion of transfected genes [25]. Finally, we incorporated a
T7 RNA polymerase transcription terminator into the con-
struct to block run-through transcription of sequences
downstream of the integration site.
To test the capability of the vector to mediate tetracycline-
regulatable expression we cloned the genes encoding fire-
fly luciferase (Luc) and red fluorescent protein (RFP) into
the multiple cloning site (Fig. 2, Methods). Spe I linearised
forms of the resulting constructs (pTcINDEX-Luc and
pTcINDEX-RFP) were then used to transform CL-Brener
[pLEW13] epimastigotes that constitutively express T7
RNA polymerase and tetR. Integration into the rRNA locus
(illustrated in Fig. 3A) was confirmed by Southern analy-
sis. This showed linkage of both of the transgenes to the
endogenous 18S rRNA gene, (for examples, see Fig. 3).
The appearance of novel fragments in the lanes containing
BMC Biotechnology 2006, 6:32 http://www.biomedcentral.com/1472-6750/6/32
Page 5 of 18
(page number not for citation purposes)
DNA from the transformants (9.5 kb with the luciferase
and 18S rRNA probes (Fig. 3B, lanes 2 and 4), 6 kb with
the 18S rRNA and RFP probes (Fig. 3B, lanes 6 and 8)),
which were absent from the CL-Brener [pLEW13] lanes,
were diagnostic of targeted integration into the non-tran-
scribed spacer region upstream of the 18S rRNA gene.
Induction of luciferase in pTcINDEX-Luc transformants
We first investigated the induction of luciferase RNA in a
polyclonal line of pTcINDEX-Luc transformed cells. Tetra-
cycline was added once to epimastigotes in early mid-log-
arithmic growth phase (approximately 106 parasites ml-1)
and aliquots removed every 24 hours for RNA purifica-
tion. No further tetracycline was added during this period,
as we wished to see if the gene returned to a repressed
state. Northern analysis was performed (Fig. 4A) and the
relative level of luciferase RNA measured at each time
point using a phosphorimager. In the lane containing
RNA from non-treated cells, the signal detected was not
significantly above the background measured from an
irrelevant piece of the membrane. This indicates a tightly
regulated system with a very low level of "leaky" transcrip-
tion. 24 hours after the addition of tetracycline, the level
of luciferase mRNA was found to have increased dramati-
cally (Fig. 4A). The mRNA levels at later time points
declined gradually. The change in luciferase RNA levels
was mirrored in the level of luciferase activity (Fig. 4B).
The enzyme level increased considerably over 24 hours
The T. cruzi inducible expression vectors pTcINDEX and pTcINDEX-C-mycFigure 2
The T. cruzi inducible expression vectors pTcINDEX and pTcINDEX-C-myc. (A) Map of pTcINDEX. The grey box 
adjacent to the multiple cloning site (MCS) indicates the ribosomal protein P2β splice acceptor site [25]. The hatched box indi-
cates the T. cruzi actin intergenic region. The black box (T) is the T7 transcriptional terminator. Black flags represent T7 pro-
moters and the oval identifies the location of the tet operator. R-NTS/P is the ribosomal non-transcribed spacer and promoter 
region used to target the construct. Roman numerals I and II indicate the two halves of the targeting sequence which are 
cloned in the opposite order to their position in the genome (see Fig. 3A). The white flag indicates the location of the pol I 
transcription start site [24]. Following insertion of a gene of interest into the MCS, the construct can be linearised with Spe I 
(dotted line) to facilitate targeting to the rRNA non-transcribed spacer region. The vector is built on a pUC19 backbone (not 
illustrated for clarity) and confers ampicillin resistance on E. coli. The sequence of the MCS is shown above the map indicating 
useful restriction sites. Nae I and Nru I were incorporated as blunt end sites to facilitate cloning of genes which contain the 
other restriction sites. (B) Map of pTcINDEX-C-myc. The inducible cassette alone is shown for clarity. The rest of the vector 
is identical to pTcINDEX. Features are as shown in A, except that the BPP1-myc fusion gene has been inserted into the Bam HI/
Nru I sites of pTcINDEX (Methods). The white box labelled "stuffer" indicates the dispensable BPP1 ORF [48]. This can be 
removed by digestion with one of the MCS enzymes and Eco RV and replaced with the gene of interest. The c-myc epitope tag 
is indicated by a green box. The Eco RV cleavage site and the translated sequence of the c-myc tag (underlined) are indicated to 
allow easy design of in-frame fusions with the epitope tag. Note the Nru I site is absent in this plasmid.
Sac I
hyg TII       R-NTS/P
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Spe I
TSTUFFER
Eco RV
Sac I
GCGGCCGCCGGCATCGATACGCGTGGATCCTCGCGA
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GCGGCCGCCGGCATCGATACGCGTGGATCC                     GATATC gag caa aag ctc att tct gaa gag gac ttgSTUFFER
I       E      Q     K      L     I    S     E      E      D     L
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I
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Integration of pTcINDEX-Luc and pTcINDEX-RFP into the ribosomal non- transcribed spacerFigu e 3
Integration of pTcINDEX-Luc and pTcINDEX-RFP into the ribosomal non- transcribed spacer. (A) Configura-
tion of correctly targeted constructs showing relevant restriction sites. R-NTS/P represents the ribosomal non-transcribed 
spacer/promoter region with the white flag indicating the promoter [24]. The targeting fragment is designed to integrate 
upstream of the rRNA transcription start. The dotted line represents the position of the Spe I site introduced into the spacer 
to facilitate linearization. This site is absent from the genomic DNA. The crossed lines indicate the sites of homologous recom-
bination. The double headed arrow shows the region of the 18S rRNA gene used as a probe when assessing integration. The 
other symbols are as in Fig. 2. The configurations for integration of pTcINDEX-Luc and pTcINDEX-RFP are shown. The 
expected fragment size following a targeted integration is illustrated below each map. (B) Southern analysis of the pTcINDEX-
Luc and pTcINDEX-RFP transformants Arrowheads indicate fragments specific to the transformants following hybridisation 
with the 18S rRNA probe. These bands also hybridise specifically to the full-length luciferase or RFP probes. Lanes 1,3,5,7 con-
tain DNA from CL-Brener [pLEW13], lanes 2 and 4 from CL-Brener:pTcINDEX-Luc [pLEW13]. Lanes 6 and 8 contain DNA 
from CL-Brener:pTcINDEX-RFP [pLEW13]. DNA in lanes 1–4 was digested with Kpn I and in lanes 5–8 with Nco I. The probes 
used are indicated below each autoradiograph. A second smaller band (1.6 kb) which hybridises to the 5' end of the RFP probe 
(lane 8) migrated off the bottom of this gel. Molecular sizes are shown in kb.
A)
B) 1  2          3   4                    5   6            7  8
18S 18SLuc RFP
10
6
4
I     II R-NTS/P 18S rRNA
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IIRFPhyg 18S
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II 18S
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and continued to increase up to 48 hours. Thereafter it
declined gradually. When the cells were washed after 24
hours exposure to tetracycline and resuspended in tetracy-
cline-free medium, the luciferase activity reached a peak at
48 hours but had declined almost to background levels
three days later (Fig 4B, dashed line).
To examine the relationship between tetracycline concen-
tration and the induction of luciferase activity, a culture of
pTcINDEX-Luc transformed CL-Brener [pLEW13] epimas-
tigotes was divided into 10 individual flasks and tetracy-
cline added at a range of concentrations (Fig. 4C). The
cells were incubated for 24 hours, then harvested and the
luciferase activity measured (Methods). There was negligi-
ble increase in luciferase activity over the level in non-
treated cells at concentrations up to and including 1 ng
ml-1. The increased activity became significant following
treatment with 5 ng ml-1 and continued to increase with
concentration before levelling off at 500 ng ml-1 (Fig. 4C).
At tetracycline concentrations of 1 or 2 µg ml-1, the extent
of induction decreased approximately two-fold, an effect
that was reproducible. At higher levels of tetracycline there
were detectable increases in parasite doubling time. The
optimal increase of luciferase activity that was achieved
was approximately 60-fold over background. This is less
than the increased level of the corresponding transcript
(Fig. 4A) and may indicate the presence of control mech-
anisms at the level of translation or instability of the luci-
ferase protein in this context.
It has previously been noted that different clones trans-
formed with the same tetracycline-regulated construct in
T. brucei will exhibit differences in both the background
level and the extent of inducible expression of the trans-
fected gene [7,9,11]. This variability has been ascribed, in
part, to epigenetic factors operating differentially on each
site of integration [26]. To examine whether this variation
occurred in T. cruzi, we isolated several clones from inde-
pendent transfections. Variability was indeed observed
(Table 1). The background level of luciferase activity var-
ied from 700 to 5000 relative light units (RLU) per 5 × 104
cells. The background remained constant in a given clone
over time. The level of induction after 24 hours varied
from 2 to 37-fold between different clones in this experi-
ment. In T. cruzi all the ribosomal RNA arrays are present
at one chromosomal locus, in contrast to the situation in
T. brucei. However the sequence across this locus is una-
vailable and it has not yet been possible to determine if
there is a relationship between the level of expression and
the site of integration.
Cell-by-cell examination of the induction process using 
RFP
To determine how individual cells responded to tetracy-
cline, we examined clones isolated following transforma-
Induction of luciferase by tetracyclineFig re 4
Induction of luciferase by tetracycline. (A) Expression 
of luciferase mRNA in a polyclonal line of tetracycline 
treated cells. pTcINDEX-Luc transformed epimastigotes 
were harvested each day following the addition of tetracy-
cline to the cultures (5 µg ml-1). Lane U is the uninduced cell 
line. Lanes 1–7 represent days following induction. 1.25 µg 
total RNA was loaded in each lane. The blot was hybridised 
with a 1.7 kb Bam HI/Sal I fragment containing the luciferase 
ORF. (B) Luciferase activity over a time course. Cells were 
induced and aliquots removed for enzyme assay at indicated 
timepoints. Dashed line: cells were induced for 24 hours 
then washed twice in tetracycline-free medium and resus-
pended in tetracycline-free medium. Solid line: cells were 
induced with tetracycline then incubated with no further 
treatment. (C) Effect of tetracycline concentration on the 
level of luciferase activity. 10 identical flasks of epimastigotes 
(as above) were treated with different concentrations of tet-
racycline for 24 hours. Cells were harvested and the luci-
ferase activity measured (Methods). The Y axis indicates the 
fold increase in luciferase activity above uninduced cells, nor-
malised, to the amount of protein present in each extract.
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tion with pTcINDEX-RFP (Methods). Epimastigotes of
clone CL:RFP C2 were maintained in tetracycline-free
medium, then an aliquot was fixed onto a slide. Tetracy-
cline was added to the remainder of the culture. An aliq-
uot of cells was removed and fixed onto a slide every 24
hours for eight days. It was apparent that RFP expression
had been highly induced by the third day, since the cell
pellet had a red tinge visible to the eye. The cells were
stained for DNA and examined by confocal microscopy.
No red fluorescence was visible in the uninduced popula-
tion (Fig. 5A). After 24 hours a few cells displayed faint
fluorescence, and after three days some cells were
extremely bright. The number of visibly fluorescent cells
increased over time. After eight days the majority of cells
exhibited some red fluorescence (Fig. 5B), although there
was variation in the level. This suggested that induction,
as measured using this parameter, does not occur at the
same rate or to the same degree in all cells of a given clonal
population.
To examine this variation further we quantified the distri-
bution of induced fluorescence in the population by FACS
analysis (Fig. 6). In this experiment the tetracycline treat-
ment was carried out at 0.5 µg ml-1, as this concentration
was optimal for expression, at least in the case of luciferase
(Fig. 4C). FACS analysis showed that in the first 24 hours
post-induction, there was a significant shift in the fluores-
cence profile, with 35% of cells showing a 10–1000 fold
increase in intensity (Fig. 6, blue line). The profile shifted
rightwards over time but did not sharpen, indicating that
fluorescence intensity varied between individual cells,
confirming the observation made by microscopy (Fig. 5).
The maximal shift was seen on day 5 (Fig. 6, green line),
when 14 % of the cells were found to exhibit a 1000–
10000 fold increase in fluorescence. Even at this stage
however, 34% of cells remained in the 0–10 arbitrary flu-
orescence units (AFU) range.
We also examined the extent of variation in both back-
ground and inducibility in the RFP expressing clones.
Again we observed a range of values (Table 2). For exam-
ple, with clone CL:RFP B1 there was only slight induction,
whereas all the other clones showed significant levels. In
this experiment, tetracycline was added every three days to
maintain the level of induction.
Addition of an rRNA promoter to pLEW13 results in higher 
background expression levels
In an attempt to produce a more homogeneous induction
profile, we constructed a derivative of pLEW13 in which
the T7 RNA polymerase and tetR genes were transcribed
from the T. cruzi rRNA promoter (Methods). Cells were
transformed with this plasmid (pTcrRNA-T7tet) and
selected at 100 µg ml-1 G418. The transformants were
resistant to 2 mg ml-1 G418, with no lag phase, indicative
that the rRNA promoter was driving high level expression
of the neo gene. These cells were then electroporated with
the inducible vector pTcINDEX-RFP. Parasites were
cloned immediately after electroporation. FACS analysis
of several independent clones confirmed that expression
of RFP was tetracycline-regulated, but again the response
was heterogeneous within clonal populations (Fig. 7).
As these clones showed a somewhat higher background
level of RFP expression (especially clone CL [pTcrRNA-
T7Tet]:RFP C6), we tested the luciferase construct in this
background. 5 clones were generated in the CL [pLEW13]
line and 5 in the CL [pTcrRNA-T7Tet] background. Each
cell line was induced for 48 hours with 250 ng ml-1 tetra-
cycline, and then assayed for luciferase activity. The results
(Table 3) indicated inducible luciferase activity in all cell
lines tested. However, there was a much lower level of
leakiness in the CL [pLEW13] cell line than the CL
[pTcrRNA-T7Tet] cell line. Whilst the former exhibited a
10–30 fold increase in luciferase activity, the latter dis-
played only a 5 to 9-fold increase. A similar effect was
noted in the inducible system created for Leishmania [18].
Consequently, for applications in which a tightly regu-
lated system is required, the CL [pLEW13] cell line
appears to be much more suitable.
Table 2: Inducible RFP expression in independent clones 
transformed with pTcINDEX-RFP.
Cell line Uninduced 0.5 µg ml-1 tet Ratio +tet/-tet
CL-RFP C2 0.3 71.8 239
CL-RFP A2 3.3 31.7 9.6
CL-RFP D6 0.7 25.8 36.8
CL-RFP D2 0.3 12.8 42.7
CL- RFP C5 1.1 17.5 15.9
CL-RFP B1 0.6 2.0 3.3
Each clone was induced with 0.5 µg ml-1 tetracycline. After 5 days, 
cells were fixed and analysed on a FacsCalibur. Controls were 
identical cultures maintained in the absence of tetracycline. The data 
are presented as percentage of cells registering greater than 6 
arbitrary fluorescence units (AFU).
Table 1: Inducible luciferase activity in independent clones 
transformed with pTcINDEX-Luc
Cell line Uninduced 0.5 µg ml-1 tet Ratio +tet/-tet
CL-Luc 1 4988 (234) 185275 (16417) 37.1
CL-Luc 2 2321 (167) 24105 (1539) 10.4
CL-Luc 3 2497 (54) 34987 (2859) 14.0
CL- Luc 4 712 (39) 3151 (464) 4.4
CL-Luc 5 4066 (386) 8333 (532) 2.0
Each clone was induced with 0.5 µg ml-1 tetracycline. After 24 hours, 
extracts were tested for luciferase activity (Methods). Each extract 
was assayed in triplicate. Controls were identical cultures maintained 
in the absence of tetracycline. The activity is represented as mean 
relative light units per 5 × 104 epimastigotes. Figures in parentheses 
represent standard error of the mean.
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Expression and localisation of epitope-tagged superoxide 
dismutase
To assign a biological role to a protein it is necessary to
know its subcellular location. Generation of specific anti-
bodies against every protein of interest is costly, time-con-
suming and not always successful. We therefore made a
derivative of pTcINDEX with a c-myc epitope tag inserted
next to the polylinker to facilitate localisation of induced
proteins (pTcINDEX-C-myc, Fig. 2B). This could also pro-
vide a simple method to follow the induction by western
blotting. To test the vector, we chose the T. cruzi superox-
ide dismutase A gene (TcSOD A), which encodes an iso-
form with a predicted mitochondrial targeting sequence.
The T. brucei orthologue of this gene is targeted to the
mitochondrion [27,28].
The TcSOD A gene was inserted into pTcINDEX-C-myc
such that the epitope tag was located at the carboxyl-ter-
minus of the fusion protein (Fig. 2B). CL-Brener
[pLEW13] epimastigotes were transformed as previously.
Two clones were characterised (A1 and A2). With both, an
induced band was visible after western blotting (Fig. 8A).
In the induced cells, the corresponding bands were visible
on a Coomassie stained gel (Fig. 8B). The upregulated
SOD was enzymatically active (Fig. 8C), with induced
cells showing a 14- and 18-fold increase over the control
lines, respectively. This represents the total cellular SOD
activity. Since there are four distinct isoforms in trypano-
somatids [27,28], it is clear that the level of SOD A over-
expression considerably exceeds 18-fold.
It was important to confirm that the SOD A was targeted
correctly since overexpression might lead to mis-targeting
or blocking of the trafficking pathway. Cells were stained
with an antibody against the carboxyl-terminal epitope
tag and examined by microscopy (Fig. 9). The immun-
ofluorescence showed targeting of the induced protein to
the single lattice-like mitochondrion of the trypanosome
with a concentration in a rod-like structure next to, or on
top of, the kinetoplast (mitochondrial) DNA. The exact
RFP expression in cloned cells by microscopyFigure 5
RFP expression in cloned cells by microscopy. Fluorescence microscopy of cloned pTcINDEX-RFP transformed epimas-
tigotes before and after induction with tetracycline (5 µg ml-1). An aliquot was removed, and fixed every 24 hours for eight 
days. Cells were examined on a Zeiss LSM 510 microscope. Panel A shows the uninduced population and panel B the same cul-
ture 8 days after induction. In each case 1: DNA stained with TOTO-3 (green), 2: RFP expression (red), 3: phase image and 4 
is a merged image.
2 RFP1 DNA
3 PHASE 4 MERGE
2 RFP1 DNA
3 PHASE 4 MERGE
A  UNINDUCED B INDUCED  
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nature of this structure is unclear, but the consistent prox-
imity to the kinetoplast suggests a possible role in protec-
tion of the replicating kDNA from reactive oxygen species.
Discussion
We have constructed a stable tetracycline-regulated
expression vector for T. cruzi and tested several of the asso-
ciated features using two marker genes, luciferase and
RFP, and an endogenous gene TcSOD A. These experi-
ments demonstrate that the system should be sufficiently
robust to have widespread application in the functional
analysis of parasite genes. Initially, we produced stable
cell lines that constitutively expressed T7 RNA polymerase
and the tetR protein using a vector system (pLEW13) orig-
inally constructed for the African trypanosome. We were
able to confirm constitutive expression of both genes in
transformed cells, even though the input plasmid com-
pletely lacked T. cruzi sequences. This type of phenome-
non has previously been observed in Leishmania [21,29],
but not in T. cruzi . Addition of the spliced leader sequence
to each transcript occurred at the same sites as used in T.
brucei (Fig. 2D). Analysis of the transformed cells indi-
cated that the pLEW13 was propagated as an episome
made up of multiple head-to-tail copies of the vector. This
organisation has commonly been observed for episomal
constructs in both Leishmania and T. cruzi [21] and is
thought to arise by insertional duplication. We used a
multicopy episome, rather than single integrated copies of
the T7 RNA polymerase and tetR genes, to decrease the
possibility of selection for mutations which could rescue
dominant-negative or conditional knockout cell lines.
Such rescue mutants occur readily in the T. brucei system
which relies on single copies of each gene [30,31]. Epi-
somes have been shown to be maintained in the absence
of selection for up to six months, and during passage
through mammalian cells and insect vectors in T. cruzi
[21,32].
The inducible expression vector (pTcINDEX) was
designed to integrate into the transcriptionally silent
ribosomal RNA spacer region. We judged this to be impor-
tant for two reasons. Firstly, so that in its repressed state,
with the tetR protein bound tightly to the tetO, the inte-
grated expression cassette did not block the transcription
of downstream genes, and secondly, so that run-through
pol II transcription occurring from upstream genes did
not interfere with repression. In trypanosomatids, linked
protein coding genes are organised into large polycis-
tronic transcription units and transcriptional termination
has not been fully characterised for any RNA polymerase.
The pTcINDEX vector was also designed so that the hyg
drug selectable marker was under the control of a consti-
tutive T7 promoter. Thus expression of T7 RNA polymer-
ase is necessary for cells to display resistance to
hygromycin and continued selection with G418 is no
longer required to maintain the presence of the pLEW13
episome.
In the pLEW13 transformed cells, our experiments indi-
cate that the level of inducible expression may vary from
gene to gene, but that any background, due to insuffi-
ciently tight repression of promoter activity, is likely to be
low. With pTcINDEX-RFP transformed cells, we were una-
ble to detect any fluorescence by microscopy, and only a
low level by FACS, in the absence of tetracycline (0.2% –
3% of cells counted depending on the clone, Fig. 6 filled
area, Table 2). Similarly, with pTcINDEX-Luc transformed
cells, detection of the luciferase transcript on northern
blots was tetracycline-dependent (Fig. 4A). However,
there was a reproducibly detectable level of enzyme activ-
ity associated with non-induced cells. This background
appeared relatively constant in a given clone, although it
did vary between clones. We also noticed that the level to
which luciferase activity was induced (up to 60-fold) was
low compared to that of the mRNA (>100-fold), suggest-
ing that expression may be regulated at the level of trans-
lation or that the luciferase protein may be less stable in
trypanosomes.
FACS analysis of expression of RFP in a cloned cell lineigure 6
FACS analysis of expression of RFP in a cloned cell 
line. Tetracycline (0.5 µg ml-1) was added and samples were 
removed at specific timepoints. The level of fluorescence in 
the population was measured by counting 5 × 103 cells per 
timepoint on a FACScan. The filled curve is the uninduced 
population. The traces for induced cells are shown as over-
laid lines: blue, 24 hours: red, 48 hours and green, 120 hours 
post-induction. The Y axis indicates the number of cells 
counted, whilst the X axis shows the level of RFP expression 
in AFU.
UNINDUCED
24 HOURS
48 HOURS
120 HOURS
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Both microscopy and FACS analysis showed that there
was a wide variation in the level of inducible expression of
RFP in individual cells, even within a cloned population,
ranging from <10- to >1000-fold. When the machinery
required for inducible expression (the T7 RNA polymerase
and tetR genes) was placed under the control of an rRNA
promoter, the induction profile did not become more
homogeneous, but the background expression increased
significantly. Thus, no advantage was gained and repres-
sion was decreased using this construct. This could be due
to high level expression of tetR resulting in aggregation
and loss of function as has been postulated in the Leishma-
nia system [18].
Cell-by-cell analysis in the manner described here, has
not, to our knowledge, been performed with the T. brucei
or Leishmania inducible expression systems, although a
heterogeneous pattern of induction has been observed
using a tetracycline-regulated promoter to drive expres-
sion of GFP in yeast [33]. This type of variation is a com-
mon feature of eukaryotic cells and is thought to reflect
the inherently stochastic nature of gene expression at the
level of both transcription and translation [34-36]. Recent
work from several laboratories has shown that stochastic
elements play a significant part in generating "noise" in
gene expression, i.e. the variation in expression of a given
protein between genetically identical individuals in a pop-
ulation under the same conditions [37-41]. Thus, the pat-
tern of RFP fluorescence observed using FACS analysis
and microscopy may be regarded as a "snapshot" of the
fluctuating levels of RFP expression that occur even within
a clonal population. Indeed, a recent report [42] has
shown that even when a marker gene (GFP) is integrated
into the T. cruzi genome under the control of a strong con-
stitutive rRNA promoter, the FACS profile of a stably
transformed cell line is remarkably heterogeneous, with
approximately 25–30% of cells expressing little or no
detectable GFP at a given time. This suggests that variation
in protein levels between individual cells may be an inher-
ent feature of T. cruzi gene expression, rather than a con-
sequence of episomal expression of the polymerase and
repressor genes. It is notable that the T. cruzi genome con-
tains many highly polymorphic multigene families
encoding surface proteins which are co-expressed in a
given population. Therefore, stochastic expression of sur-
face antigens between individual cells of a population
may be an important immune evasion strategy [43]. It has
been hypothesised that micro-organisms benefit from
noise in gene expression as this allows a population to
respond more rapidly to changes in their environment
and decreases the chances of cells becoming mired in
inappropriate epigenetic states [44].
The availability of our inducible expression system will
provide new approaches for the functional analysis of
genes in T. cruzi. It will allow the study of proteins that
may be toxic if constitutively expressed, enable the gener-
FACscan analysis of expression of RFP in 3 independent clones i the CL [pTcrRNA-T7tet ] backgroundigure 7
FACscan analysis of expression of RFP in 3 independ-
ent clones in the CL [pTcrRNA-T7tetR] background. 
Tetracycline (0.5 µg ml-1) was added and samples were 
removed and fixed after 6 days. The level of fluorescence in 
the population was measured by counting 5 × 103 cells per 
timepoint. The filled area indicates the uninduced cells, while 
the green line represents the induced population. The Y axis 
indicates the number of cells counted, whilst the X axis 
shows the level of fluorescence in AFU.
Cl [pTcrRNA-T7tet]:RFP A5
Cl [pTcrRNA-T7tet]:RFP C6
Cl [pTcrRNA-T7tet]:RFP D1
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ation of conditional knockouts of essential genes and
facilitate functional knockouts by means of overexpres-
sion of dominant-negative protein mutants. The level of
overexpression achieved with SOD A (Fig. 8) suggests that
a dominant-negative approach will be feasible, since in
such a system the mutated protein must be expressed at
significantly higher levels than the endogenous enzyme.
Modulation of expression levels by changing the concen-
tration of tetracycline could also be important for condi-
tional knockout experiments. This will enable the
transfected gene to be expressed at a similar level to the
endogenous copy, thereby preventing unforeseen pheno-
typic consequences due to overexpression. An advantage
of using tetracycline as the inducer is that the expression
system can be applied to the study of enzyme function
throughout the life-cycle. For example, it should be possi-
ble to investigate the development of transformed para-
sites within tissue-culture cells using the tetracycline
analogue doxycycline, which has been used to regulate
murine gene expression in transgenic (Tet-On) mice [45].
The combination of episomally expressed T7 RNA
polymerase and tetR with an inducible vector which can
integrate into the rRNA locus in both group I and group II
parasites also means that this system is transferable to any
strain of T. cruzi. pTcINDEX and pTcINDEX-C-myc are
freely available to members of the trypanosomatid
research community.
Conclusion
We have designed and tested a user-friendly tetracycline-
regulatable expression vector, pTcINDEX, for the proto-
zoan parasite T. cruzi. This vector has been used to gener-
ate cell lines bearing inducible copies of luciferase, RFP
and SOD A. The levels of repression and induction
achieved lead us to believe that this vector will be useful
for creating both conditional knockouts and dominant-
negative mutants of T. cruzi, an organism for which RNAi
based approaches are not applicable.
Methods
Parasite maintenance and genetic manipulation
Epimastigotes of T. cruzi CL-Brener were maintained at
27°C in RPMI-1640 medium as described previously
[46], except that we used 5% tetracycline-free fetal calf
serum (Autogen Bioclear). Parasites were transformed by
electroporation using a Bio-Rad Gene Pulser II, placed
into fresh medium and incubated for 48 hours to allow
expression of the drug-selectable marker. The appropriate
drug was then added (G418 at 100–200 µg ml-1 or hygro-
mycin at 100 µg ml-1) and the cells incubated for a further
four to six weeks to allow selection of transformants. For
direct cloning, parasites were resuspended in 24 ml of
fresh medium directly after electroporation. 1 ml was then
transferred to each well of a 24-well plate and the cells
allowed to grow for 48 hours prior to addition of the
selective drug. Typically, between 2 and 5 clones were gen-
erated per 24-well plate.
Plasmid construction
The inducible expression vector pTcINDEX (Fig. 2) was
based on the T. brucei RNAi vector pZJM [8](a gift from
Paul Englund). First, the inverted promoter fragment of
pZJM, which contains bi-directional T7 promoters, was
isolated by digestion with Kpn I and Bam HI. This frag-
ment was then subcloned into pGEM3zf+ (Promega) to
produce vector pGEMT7Tet2. In parallel, a hyg gene
flanked by the processing signals from the T. cruzi glyco-
somal glyceraldehdye-3-phosphate dehydrogenase
gene[21,46] was inserted into the Eco RV site of pBlue-
script KS(-). A constitutive T7 promoter was then inserted
upstream of the hyg gene after generation of the appropri-
ate fragment by PCR. This 2.4 kb cassette was isolated fol-
lowing Kpn I and Sac I digestion and sub-cloned into
Table 3: Inducible luciferase activity in independent clones transformed with pTcINDEX-Luc in pLEW13 or pTcrRNA-T7Tet 
background.
Cell line Uninduced 0.25 µg ml-1 tet Ratio +tet/-tet
CL-LA1N (pLEW13) 338 (16) 9831 (411) 29
CL-L1D4 (pLEW13) 3016 (36) 75792 (4195) 25
CL-LB5N(pLEW13) 393 (7) 7426 (281) 19
CL-L4B1(pLEW13) 303 (5) 3196 (256) 11
CL-L4D5(pLEW13) 848 (37) 18003 (613) 21
CL-L1B6 (pTcrRNA-T7Tet) 83249 (2920) 412729 (33287) 5
CL-L1C4 (pTcrRNA-T7Tet) 76625 (4521) 709201 (12746) 9
CL-L2A4 (pTcrRNA-T7Tet) 91785 (4306) 425708 (15432) 5
CL-L2D4 (pTcrRNA-T7Tet) 92374 (7511) 769333 (44171) 8
CL-L1A6 (pTcrRNA-T7Tet) 86922 (2736) 316358 (16381) 3
Each clone was induced with 0.25 µg ml-1 tetracycline. After 48 hours, extracts were tested for luciferase activity (Methods). Each extract was 
assayed in triplicate. Controls were identical cultures maintained in the absence of tetracycline. The activity is represented as mean relative light 
units per 5 × 104 epimastigotes. Figures in parentheses represent standard error of the mean.
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pGEMT7Tet2, upstream of the fragment derived from
pZJM, to create pGEMhygT7-3. Since the pGEM backbone
contains an additional unwanted T7 promoter, the whole
insert fragment was liberated by Bam HI/Sac I digestion
and inserted into pUC19∆H (pUC19 with the Hind III site
deleted by end-filling).
The ribosomal RNA non-transcribed spacer and promoter
region were amplified from genomic DNA of T. cruzi in
two pieces of 1.8 kb and 0.3 kb to allow the introduction
of a unique Spe I site for vector linearization prior to trans-
fection. These pieces were generated using the primer
pairs:
5'-TTTACTAGTAGCTCGGTGCACCCTG, 5'-GGGGAGCT-
CACACAAATGGACGGTTA and, 5'-GGGGAGCTCATTT-
GTGTCTAGTACATC, 5'-
GGGACTAGTCTGAGGCATGCATGGCTA.
Inducible expression of TcSOD AFig re 8
Inducible expression of TcSOD A. Two clones containing pTcINDEX-SOD A9E10 on a CL-Brener [pLEW13] background 
were induced with 0.25 µg ml-1 tetracycline for five days. Replicate cultures were grown in the absence of tetracycline. Protein 
extracts were made and analysed by SDS-PAGE, western blotting and enzyme assay. A) Western blot of a gel stained with the 
mouse monoclonal 9E10. A single band of approximately 25 kDa was recognised by the antibody. B) Coomassie stained SDS-
PAGE gel showing lysates from control and induced populations of clones A1 and A2. Note the intense band appearing in the 
induced lanes, at the position of the band recognised by the antibody in A. C) Relative SOD activities of the trypanosome 
lysates as measured using the SOD 525 assay system. Each assay was performed in triplicate. Clone A1 showed a 14:1 ratio of 
SOD activity between induced and uninduced cells, while clone A2 showed an 18:1 ratio.
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The fragments were ligated together then cloned into the
Sac I site immediately downstream of the hyg cassette (as
shown in Fig. 2) to produce plasmid pTcIRi. To construct
the inducible expression vector, we modified pTcIRi by
removing the antisense promoter and adding a polylinker
and RNA processing signals. Briefly, pTcIRi was partially
digested with Sac I and Hind III. The Sac I/Hind III frag-
ment containing the hyg gene and the sense strand induc-
ible promoter was cloned into pGEM3zf+ (Promega) to
create pGEMTcI. The T7 transcriptional terminator from
pTcIRi was amplified with primers 5'-
TTTCTCGAGCGGCCGCCGGCATCGATACGCGT-
GGATCCTCGCGAATCAGGTGCTAGCCCGCT and 5'-
TTTAAGCTTGATCCCCGGATATAGTT. This fragment,
which also incorporated a multiple cloning site (under-
lined, Fig. 2A), was inserted into Xho I/Hind III digested
pGEMTcI.
The splice acceptor site from the ribosomal protein P2β
locus was amplified from pTREX-n [25] (a gift from Mari-
ano Levin), using primers which added an Xho I site to the
5' end and a Not I site to the 3'end. This 212 bp fragment
was cloned into the corresponding sites of the polylinker.
The actin intergenic sequence [Acc. No. U20234], which
contains a putative polyadenylation signal, was amplified
from genomic DNA of T. cruzi using primers: 5'-CCCG-
GATCGTCGCGAGGCAGGCCCAAGCA and 5'-CCCGA-
TATCGTCAGACATCCTTAGAA. The resulting 424 bp
fragment was then digested with Bam HI and Eco RV and
cloned into the Bam HI and Nru I sites of the polylinker.
Immunofluorescence localisation of epitope tagged TcSOD AFigure 9
Immunofluorescence localisation of epitope tagged TcSOD A. Cells were induced as in Fig [8]. The parasites were 
fixed in paraformaldehyde and stained with mouse monoclonal anti-c-myc 9E10. Slides were examined on a Zeiss LSM 510 con-
focal microscope. The epitope tagged protein is shown as green fluorescence with the DNA stained red. Arrows indicate the 
strong staining of a structure adjacent to the kinetoplast (K). The nucleus is indicated (N). The white bar indicates 5 µm. The 
phase image is shown for comparison. Both images show cells in the process of dividing.
NK
MERGE
SOD A
DNA
DNA SOD A
MERGE
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The entire insert was again transferred to pUC19 via a par-
tial Sac I/Hind III digest to produce the final expression
construct pTcINDEX (Fig. 2).
The luciferase coding sequence was obtained from pGEM-
luc (Promega). The plasmid was digested with Sal I and
end-filled by the Klenow fragment. The gene was then
excised by digestion with Bam HI. pTcINDEX was digested
with Bam HI and Nru I and the luciferase gene was ligated
into the vector to produce pTcINDEX-Luc. To obtain the
gene encoding the red fluorescent protein (RFP), con-
struct pTEX-Red [47] was first digested with Bam HI and
Bgl II and re-ligated to delete awkward restriction sites.
The modified plasmid was then cut with Spe I and the
ends filled by Klenow treatment. The RFP gene was liber-
ated by digesting the linear plasmid with Cla I and cloned
into Nae I/Cla I sites of pTcINDEX to create pTcINDEX-
RFP.
pLEW13 was modified to include a T. cruzi rRNA pro-
moter to drive expression of the T7 RNA polymerase, neo
and tetR genes. Briefly the Sac I fragment carrying the
rRNA promoter and upstream spacer region was removed
from pTcINDEX and subcloned into pUC19 to make
pUC-TcrRNA. The T7 RNA polymerase, neo and TetR genes
were removed from pLEW13 on a 5.9 kb fragment using
EcoRV and Stu I. This fragment was then cloned into the
unique Spe I site in the rRNA promoter fragment of pUC-
TcrRNA, such that the transcription initiation point was
upstream of the T7 polymerase gene. This derivative of
pLEW13 was named pTcrRNA-T7Tet.
We created an epitope tagging vector by cloning the BPP1-
myc fusion gene from pTEX-BPP1-9E10 into Bam HI/Nru
I digested pTcINDEX [48]. This fusion gene contains a
unique Eco RV site between the BPP1 ORF and the c-myc
tag such that any gene of interest can replace the BPP1
coding sequence and be cloned in-frame with the tag (Fig.
2B). The epitope tag encodes the sequence EQKLISEEDL*,
where * indicates a translational stop. This vector was
named pTcINDEX-C-myc where the uppercase C denotes
that the tag is fused to the carboxyl terminal of the protein
of interest. To make an inducible tagged copy of TcSOD A,
the gene (>Tc00.1047053509775.40 [49]) was amplified
from genomic DNA of the CL-Brener strain using the fol-
lowing primers:
SOD A F: gggggatccATGTTGAGACGTGCGGTGAA
SOD A R: ggttgatatcTTTTATTGCCTGCGCAT
where underlining indicates restriction sites introduced
for ease of cloning. The 699 bp product was digested with
Bam HI and Eco RV and ligated into Bam HI/Eco RV
digested pTcINDEX-C-myc, such that the SOD A ORF was
in-frame with the carboxyl terminal epitope tag under the
control of the inducible T7 promoter. The construct was
confirmed by DNA sequencing.
Nucleic acid analysis
DNA and RNA were prepared and purified using Qiagen
kits as per manufacturer's instructions. RNA was quanti-
fied using a 2100 Bioanalyzer with RNA 6000 Nano
Labchip (Agilent). Southern and northern blotting were
carried out using standard protocols. Reverse transcriptase
PCR (RT-PCR) was carried out using the Access RT-PCR kit
(Promega) and primers:
Spliced Leader sense 5'-GGGGGATCCACAGTTTCTGTAC-
TATATTG
T7 Polymerase antisense 5'-TCGTAAGACTCATGCTCAA
Neo antisense 5'-CCTCGTCCTGACAGTTCAT
tetR antisense 5'-TGCCTATCTAACATCTCA
The products were cloned into pGEM-T (Promega) and
sequenced using a dye terminator cycle-sequencing kit
(Applied Biosystems) and an ABI Prism 377 DNA
sequencer. For CHEFE analysis parasite blocks were made
as described [50]. The chromosomes were resolved on a
CHEFmapper system (Bio-Rad) using the auto-algorithm
and conditions as detailed in figure legends.
Induction of gene expression
For induction experiments, epimastigotes were cultured
in 25 cm3 flasks at 27°C and maintained in logarithmic
growth phase (106 – 107 cells ml-1). Control cells were
grown in tetracycline-free medium, whilst the induced
cells were cultured in medium supplemented with the
stated concentration of tetracycline. We found that the
doubling time of wild type parasites was unaffected by
low concentrations of tetracycline, but was increased by
13% at 5 µg ml-1 and by 30% at 10 µg ml-1. Inductions
were carried out over variable time courses as stated in fig-
ure legends.
Luciferase assays
Epimastigotes transformed with pTcINDEX-Luc were
grown as described above. At each time point an aliquot
was removed, pelleted and washed in PBS (137 mM NaCl,
4 mM Na2HPO4, 1.7 mM KH2PO4, 2.7 mM KCl). Cell pel-
lets were frozen in liquid nitrogen and stored at -80°C.
For the luciferase assay, the pellet was resuspended in 500
µl of cell culture lysis reagent (Promega). Lysates were vor-
texed for 15 seconds and the debris removed by centrifu-
gation. Activity was measured using the luciferase assay
system (Promega) and light emission measured on a β-
plate counter (Wallac). The linear detection limits of the
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counter were measured using serial dilutions of Quanti-
Lum recombinant luciferase (Promega). Protein concen-
trations were determined by the BCA assay (Pierce) using
equivalent amounts of cells lysed in PBS, as the lysis rea-
gent is incompatible with the protein assay.
Fluorescence microscopy and FACS analysis of RFP 
expression
RFP expression was examined by confocal microscopy on
a Zeiss LSM 510 Axioplan microscope. Transformed para-
sites were induced as described above. At each time point,
an aliquot of cells (107) was removed, pelleted, washed in
PBS and then fixed for 30 minutes in 4% paraformalde-
hyde/PBS. Cells were then washed and resuspended in 5
ml PBS. 20 µl of the suspension was dotted onto a single
well of a 12-well slide. DNA was stained by adding 50 nM
TOTO-3 (Molecular Probes) in 10 mg ml-1 RNAse A/0.1%
saponin/PBS to each well, incubating at room tempera-
ture for 20 minutes, then washing twice in PBS. Slides
were mounted in 1:1 PBS/glycerol. For FACS analysis,
cells were fixed as above and finally resuspended at 107
parasites ml-1. 5 × 103 – 104 cells per time point were
counted on a FacScan or FacsCalibur (Becton Dickinson).
Data were analysed using Cellquest™ software (BD Sci-
ences).
Protein extraction and analysis
For western blot and SOD activity assays, cells were pel-
leted, and washed once in PBS. The cells were pelleted
again and resuspended in lysis buffer (PBS supplemented
with proteinase inhibitors, Roche). The cell suspension
was freeze-thawed three times in liquid nitrogen then son-
icated. Membrane debris was removed by centrifugation
(10,000 g for 10 mins). The supernatant was removed to
a sterile tube and stored at -80°C. SDS-PAGE and western
blotting were carried out as per standard protocols. The
western blots were probed with mouse monoclonal c-Myc
(9E10) (cat no. sc-40, Santa Cruz Biotechnology Inc.)
diluted 1:2000. For SOD activity assays the Bioxytech™
SOD 525 (Oxis Research) kit was used as per manufac-
turer's instructions.
Immunofluorescence
To check the localisation of the tagged SOD A, epimastig-
otes were fixed in 4% paraformaldehyde and dried onto
slides. The slides were stained with mouse monoclonal c-
Myc (9E10) (diluted 1:200) and then Alexafluor 488 con-
jugated goat anti-mouse (diluted 1:400 Molecular
Probes). DNA was stained with DAPI. Slides were exam-
ined on a Zeiss LSM 510 confocal laser scanning micro-
scope.
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